Weekly News

Venture Category: Biotechnology


This week's biotechnology venture startup news



Akadeum Life Sciences - Researcher Spotlight: Mouse B Cell Isolation Kit
“The resulting sample looked perfect after using microbubbles – very happy with the product.” Get an inside look into how products from Akadeum Life Sciences perform in real-world research that is happening in laboratories across the country. A research group at the University of California San Francisco recently used the Mouse B Cell Isolation Kit from Akadeum Life Sciences in the course of their research into understanding how autoreactive B ...
The post Researcher Spotlight: Mouse B Cell Isolation Kit appeared first on Akadeum Life Sciences.
    Ariel Precision Medicine - How do Race and Ethnicity Affect Genetic Testing?
    Introduction The term “genetic testing” actually refers to a wide range of different tests, each with their own purpose. Some testing methods focus on single variants at specific points in the human genome, while others take account of the whole genome. In some conditions, genetic testing may reveal an underlying genetic variant responsible for a […]
    The post How do Race and Ethnicity Affect Genetic Testing? appeared first on Ariel Precision Medicine.
    
      Arranta Bio - Arranta Bio Named Finalist for Gainesville Chamber Life Science Company of the Year
      Concluding a year of growth, challenge and agility, we’re proud to announce that Arranta Bio has been a named Life Science Company of the Year finalist in the Gainesville Chamber of Commerce 2020 Business Awards. This honor marks the second year Arranta, which acquired Gainesville-based biotechnology CDMO Captozyme in November 2019, has been chosen for...
      The post Arranta Bio Named Finalist for Gainesville Chamber Life Science Company of the Year appeared first on ArrantaBio.
      
        BioSapien Inc - Researching Infectious Diseases: From HIV to COVID-19
        The post Researching Infectious Diseases: From HIV to COVID-19 appeared first on Conduct Science.
        
          BioSapien Inc - The Conduct Science Podcast: Earth
          The post The Conduct Science Podcast: Earth appeared first on Conduct Science.
          
            Casma Therapeutics - Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
            CAMBRIDGE, Mass. & COPENHAGEN, Denmark- December 1, 2020-Casma Therapeutics, Inc. and Vipergen ApS announced today the signing of a drug discovery agreement. Under the terms of the agreement, Vipergen will apply its proprietary high-fidelity DNA-encoded library (DEL) technology platform to discover novel small-molecule drug leads against a broad range of undisclosed Casma discovery targets. Casma […]
              Cota Healthcare - Nadine Peters Joins the COTA Team as Chief Legal Officer
              COTA has a new Chief Legal Officer: healthcare and data privacy attorney Nadine Peters. She spoke with our team about her background and why she's excited to be working at COTA based on the company's mission & team. 
              The post Nadine Peters Joins the COTA Team as Chief Legal Officer appeared first on COTA Healthcare.
              
                Erasca - Director/Senior Director, Clinical Supply Chain
                Position Title: Director/Senior Director, Clinical Supply Chain   Reports To: TBD Dept. Name: Clinical Position Summary: Erasca is a San Diego based biotechnology company focused on discovering and developing precision medicines for the benefit of patients with cancer. We are advancing multiple programs targeting biological drivers of cancer and are pursuing additional pipeline expansion opportunities […]
                The post Director/Senior Director, Clinical Supply Chain first appeared on Erasca.
                  Imago BioSciences - Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong
                  Study continues to build momentum toward completing enrollment, dosing first patient in Hong Kong South San Francisco, Calif. Nov. 30,... READ MORE
                  The post Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong appeared first on Imago Bio.
                  
                    Kalocyte - KaloCyte in the News: UMB Startups Receive Support from Maryland Momentum Fund
                    The University System of Maryland (USM) continues to aid entrepreneurs at UMB and throughout the state, including KaloCyte, with the $10 million Maryland Momentum Fund (MMF).
                    The post KaloCyte in the News: UMB Startups Receive Support from Maryland Momentum Fund appeared first on KaloCyte.
                    
                      Mindleap Health - Stealing Fire: How Silicon Valley, the Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work
                      This article originally appeared on integration-station.com and was reposted with permission from the original author. Introductory Thoughts: Jamie Wheal and Steven Kotler threaded the cultural needle that needed to happen; bringing awareness to Middle America on the tools that induce altered states of consciousness and how they can help you. Jamie & Steven effectively wrapped awareness of […]
                      The post Stealing Fire: How Silicon Valley, the Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work appeared first on Mindleap.
                      
                        Mirum Pharmaceuticals - Senior Clinical Project Manager
                        
                        
                          Nurix - Director/Senior Medical Director
                          Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to […]
                          The post Director/Senior Medical Director appeared first on Nurix.
                          
                            OmniSeq - Cancer-testis antigen detection by targeted RNA sequencing
                            Abstract Background: Cancer-testis antigens (CTAs) have restricted expression in normal adult tissues but have been found to be overexpressed in multiple tumors.  This and their ability to elicit spontaneous cellular and humoral immune responses have rendered CTAs as good candidate targets for cancer immunotherapy. CTA overexpression is variable and influenced by factors such as tumor […]
                            The post Cancer-testis antigen detection by targeted RNA sequencing appeared first on OmniSeq.
                            
                              Pear Therapeutics - Pear Therapeutics to Participate in the 2020 RBC Capital Markets Healthcare Private Company Conference
                              Boston and San Francisco, December 2, 2020 – Pear Therapeutics, Inc. today announced that Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private Company Conference on Wednesday, December 16 at 10:00 a.m. Eastern Time. Pear Therapeutics is a privately held,… Read more
                              The post Pear Therapeutics to Participate in the 2020 RBC Capital Markets Healthcare Private Company Conference appeared first on Pear Therapeutics.
                              
                                Pheronym - Communicating with nematodes for better farming
                                This amazing video prepared by the Biomimicry Institute and the Ray of Hope Prize explains how Pheronym taps into nematodes’ pheromone communication system for eco-friendly sustainable farming. We thank the Biomimicry Institute and Ray of Hope Prize.
                                  QurAlis - QurAlis to Present Data on Two Precision Medicine Programs (Kv7 and TBK1) at MNDA 31st International Symposium on ALS/MND
                                  Press Release Home News Press Release Cambridge, MA, December 2, 2020 — QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced that the company will present two posters featuring data from two of the company’s preclinical precision medicine ALS programs at the Motor Neuron Disease...
                                    Relievant Medsystems - Customer Service Leader
                                    Summary:
                                    This position is responsible for providing highly responsive, best-in-class customer support to both internal and external customers. The primary responsibility of this role is to partner with Relievant Territory Managers and internal teams to deliver a positive customer experience with Relievant products and services.
                                    The post Customer Service Leader appeared first on Relievant.
                                    
                                      Vital Vio - Orlando-Based ForgeGreen Bio Partners with Vyv to Offer Continuous-Use Antimicrobial Light Technology
                                      ORLANDO, Fla.–ForgeGreen Bio, leading disinfectant management group based in Orlando, Florida, today announced a partnership with VyvTM (formerly Vital Vio) to provide continuous-use antimicrobial lighting for residential, commercial and industrial applications as part of its portfolio. This addition to its portfolio of best-in-class solutions is helping create safer, cleaner spaces to families, businesses, and communities. “Adding […]
                                      The post Orlando-Based ForgeGreen Bio Partners with Vyv to Offer Continuous-Use Antimicrobial Light Technology appeared first on Vyv.